Caliper Technologies - CALP Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Caliper Technologies - CALP

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (99)	1/9/2007 3:41:45 PM
From: tuck	of 114

>>Genentech buys oncology program from Amphora Tuesday January 9, 1:39 pm ET Genentech Inc. will buy an oncology program of Amphora Discovery Corp. for an undisclosed price. Amphora did not disclose other terms of the deal on Tuesday. Amphora is a small molecule drug discovery company based in Research Triangle Park, N.C. South San Francisco-based Genentech (NYSE: DNA - News) is buying Amphora's entire program for an unnamed oncology target. Nicholas Hodge is Amphora's founder and chief scientific officer. He works in Los Altos. Published January 9, 2007 by San Francisco Business Times<< Amphora was spun out of Caliper, which I believe still has a sizeable stake, though I don't how big. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next